Development of anti-coronavirus drug candidates by controlled evolution

  • Funded by Ministry for Innovation and Technology (Hungary)
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Ministry for Innovation and Technology (Hungary)
  • Principal Investigator

    N/A

  • Research Location

    Hungary
  • Lead Research Institution

    EvolVeritas Ltd.
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The first step in coronavirus infection is the entry of the virus into human cells. The project aims to develop a specific, highly effective inhibitor for the treatment and even prevention of coronavirus infection.